FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

23429111000001102: Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 03-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    76715801000001110 Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    76715901000001116 Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet Is a Co-careldopa 50mg/200mg modified-release tablets 60 tablet false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet Has AMP Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet Has specific active ingredient Levodopa false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet Has specific active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet Has dispensed dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Carbidopa false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet Legal category Prescription only medicine - legal category (qualifier value) false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet Is a Actual medicinal product pack false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet Has specific active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet Has basis of strength substance Carbidopa false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start